![]() |
|
|
Vol. 297, Issue 2, 727-735, May 2001
Department of Physiology & Biophysics, University of Illinois at
Chicago College of Medicine, Chicago, Illinois
Calcium channels modulate cell function by controlling Ca2+
influx. A main component of these proteins is the
2/
subunit. Nevertheless, how this subunit regulates channel activity in situ is
unclear. Gabapentin (GBP), an analgesic and anti-epileptic agent with
an unknown mechanism of action, specifically binds to the
2/
subunit. Using the patch clamp technique, we tested the effects of GBP
on Ca2+ currents from dorsal root ganglion (DRG) cells, the
mediators of pain perception, to determine how GBP binding modifies
channel activity. In DRGs, GBP significantly reduced whole cell
Ca2+ current amplitude at positive membrane potentials when
a pulse preceded the test pulses or when cells were stimulated with a train of pulses. In control cells, neither prepulse depolarization nor
pulse trains reduced Ca2+ currents at positive potentials.
GBP did not reduce the low-voltage activated Ca2+ current
under any experimental condition. Similar to DRG cells, GBP attenuated
Ca2+ current in skeletal myotubes at positive membrane
potentials in the presence of a depolarizing prepulse. However, GBP did
not significantly alter Ca2+ currents in cardiac myocytes.
Reverse transcription-polymerase chain reaction was used to
confirm expression of the
2/
subunit in these cells. Each cell
type expressed multiple isoforms of
2/
. Muscle cells showed a
more variable expression of
2/
subunits than did DRG cells. Our
results suggest a possible participation of the
2/
subunit in the
action of GBP. Our data also indicate that GBP inhibits
Ca2+ channels in a use- and voltage-dependent manner at a
therapeutically relevant concentration.
This article has been cited by other articles:
![]() |
S. Koc, D. Memis, and N. Sut The Preoperative Use of Gabapentin, Dexamethasone, and Their Combination in Varicocele Surgery: A Randomized Controlled Trial Anesth. Analg., October 1, 2007; 105(4): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tuccori, G. Lombardo, F. Lapi, A. Vannacci, C. Blandizzi, and M. Del Tacca Gabapentin-Induced Severe Myopathy Ann. Pharmacother., July 1, 2007; 41(7): 1301 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Micheva, C. P. Taylor, and S. J Smith Pregabalin Reduces the Release of Synaptic Vesicles from Cultured Hippocampal Neurons Mol. Pharmacol., August 1, 2006; 70(2): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Boileau, J Martel-Pelletier, J Brunet, D Schrier, C Flory, M Boily, and J-P Pelletier PD-0200347, an {alpha}2{delta} ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKC{alpha} dependent effect Ann Rheum Dis, May 1, 2006; 65(5): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Remy and H. Beck Molecular and cellular mechanisms of pharmacoresistance in epilepsy Brain, January 1, 2006; 129(1): 18 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Garcia, T. Shah, and J. Garcia Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1048 - C1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Alden and J. Garcia Dissociation of charge movement from calcium release and calcium current in skeletal myotubes by gabapentin Am J Physiol Cell Physiol, September 1, 2002; 283(3): C941 - C949. [Abstract] [Full Text] [PDF] |
||||